These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 28689947
1. A Novel Iliac Morphology Score Predicts Procedural Mortality and Major Vascular Complications in Transfemoral Aortic Valve Replacement. Blakeslee-Carter J, Dexter D, Mahoney P, Ahanchi S, Steerman S, Larion S, Cain B, Panneton JM. Ann Vasc Surg; 2018 Jan; 46():208-217. PubMed ID: 28689947 [Abstract] [Full Text] [Related]
2. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation. Uguz E, Gokcimen M, Ali S, Alsancak Y, Bastug S, Ahmet Kasapkara H, Canyigit M, Hıdıroglu M, Sener E. J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061 [Abstract] [Full Text] [Related]
3. Iliofemoral artery lumen volume assessment with three dimensional multi-detector computed tomography and vascular complication risk in transfemoral transcatheter aortic valve replacement. Hammer Y, Landes U, Zusman O, Kornowski R, Witberg G, Orvin K, Levi A, Codner P, Vaknin-Assa H, Nassar M, Shafir G, Assali A, Hamdan A. J Cardiovasc Comput Tomogr; 2019 Mar; 13(1):68-74. PubMed ID: 30340961 [Abstract] [Full Text] [Related]
4. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR). Herold J, Herold-Vlanti V, Sherif M, Luani B, Breyer C, Bonaventura K, Braun-Dullaeus R. BMC Cardiovasc Disord; 2017 Dec 20; 17(1):298. PubMed ID: 29262768 [Abstract] [Full Text] [Related]
5. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach. Drafts BC, Choi CH, Sangal K, Cammarata MW, Applegate RJ, Gandhi SK, Kincaid EH, Kon N, Zhao DX. Catheter Cardiovasc Interv; 2018 Jun 20; 91(7):1354-1362. PubMed ID: 29024382 [Abstract] [Full Text] [Related]
6. Predicting vascular complications during transfemoral transcatheter aortic valve replacement using computed tomography: a novel area-based index. Krishnaswamy A, Parashar A, Agarwal S, Modi DK, Poddar KL, Svensson LG, Roselli EE, Schoenhagen P, Tuzcu EM, Kapadia SR. Catheter Cardiovasc Interv; 2014 Nov 01; 84(5):844-51. PubMed ID: 24659145 [Abstract] [Full Text] [Related]
7. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. Chieffo A, Petronio AS, Mehilli J, Chandrasekhar J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail GW, Sharma S, Ferrer MC, Naber C, Kievit P, Faggioni M, Snyder C, Morice MC, Mehran R, WIN-TAVI Investigators. JACC Cardiovasc Interv; 2016 Aug 08; 9(15):1589-600. PubMed ID: 27491609 [Abstract] [Full Text] [Related]
8. Frequency and Effect of Access-Related Vascular Injury and Subsequent Vascular Intervention After Transcatheter Aortic Valve Replacement. Dencker D, Taudorf M, Luk NH, Nielsen MB, Kofoed KF, Schroeder TV, Søndergaard L, Lönn L, De Backer O. Am J Cardiol; 2016 Oct 15; 118(8):1244-1250. PubMed ID: 27638098 [Abstract] [Full Text] [Related]
9. Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era. Rogers T, Gai J, Torguson R, Okubagzi PG, Shults C, Ben-Dor I, Satler LF, Waksman R. Catheter Cardiovasc Interv; 2018 Nov 01; 92(5):964-971. PubMed ID: 30019839 [Abstract] [Full Text] [Related]
10. Trends in vascular complications and associated treatment strategies following transfemoral transcatheter aortic valve replacement. Ullery BW, Jin R, Kirker EB, Hayes G, Siwek L, Brevig J, Hodson RW, Spinelli KJ. J Vasc Surg; 2020 Oct 01; 72(4):1313-1324.e5. PubMed ID: 32169358 [Abstract] [Full Text] [Related]
11. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation. Fink N, Segev A, Barbash I, Bogdan A, Hamdan A, Mazin I, Maor E, Hay I, Guetta V, Fefer P. Catheter Cardiovasc Interv; 2016 Feb 01; 87(2):341-6. PubMed ID: 26010839 [Abstract] [Full Text] [Related]
17. Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR. Holper EM, Kim RJ, Mack M, Brown D, Brinkman W, Herbert M, Stewart W, Vance K, Bowers B, Dewey T. Catheter Cardiovasc Interv; 2014 Feb 15; 83(3):457-64. PubMed ID: 23703878 [Abstract] [Full Text] [Related]
18. Impact of percutaneous femoral arteriotomy closure using the MANTATM device on vascular and bleeding complications after transcatheter aortic valve replacement. De Palma R, Settergren M, Rück A, Linder R, Saleh N. Catheter Cardiovasc Interv; 2018 Nov 01; 92(5):954-961. PubMed ID: 29575678 [Abstract] [Full Text] [Related]
19. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis. Abu Saleh WK, Tang GH, Ahmad H, Cohen M, Undemir C, Lansman SL, Reyes M, Barker CM, Kleiman NS, Reardon MJ, Ramlawi B. Catheter Cardiovasc Interv; 2016 Jul 01; 88(1):135-43. PubMed ID: 26603266 [Abstract] [Full Text] [Related]
20. Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched Analysis. Brener MI, Olds A, Nemeth S, Kurlansky P, Nazif TM, Vahl TP, Khalique OK, Hamid NB, Patel A, Ng VG, Chen S, Cahill TJ, Rahim HM, Hahn RT, Bapat V, Sarraf M, Ahmed MI, Leon MB, Kodali S, Eudailey KW, George I. J Am Heart Assoc; 2021 Aug 17; 10(16):e020491. PubMed ID: 34376060 [Abstract] [Full Text] [Related] Page: [Next] [New Search]